Sinclair CEO Chris Spooner talks about bringing Silhoutte InstaLift to the US
Sinclair Pharma CEO Chris Spooner has spoken about bringing Silhouette InstaLift to the US market. In an interview with Steven Dayan, Cooper explained how the non-surgical treatment, that claims to be the first lifting injectable, was "resorbable" and didn't just smooth skin, but helped "lift it for the first time". He also explained why he chose ThermiGen from various companies to distribute Silhouette InstaLift, saying the company was "super-motivated" and "highly entrepreneurial".

Chris Spooner talks with Steven Dayan, MD, FACS about bringing Silhouette InstaLift to the US. InstaLift differs from other generations of sutures because it's resorbable and has cones that hook the subdermal fat layer to reposition volume under the skin.

'The company has other products in the pipeline, including a biphasic hyaluronic acid filler and a second generation collagen stimulator. Sinclair Pharma CEO Chris Spooner sat down with host Steve Dayan to discuss the company's long-term plans in the US and its partnership with ThermiGen.'

Click here to view the full interview on Mordern Aesthetic TV.

For more information on Silhouette Instalift visit the website here.